References analysis of the Wikipedia article "Receptor de estrógeno" in the Spanish version

doi.org

dx.doi.org

Dahlman-Wright K, Cavailles V, Fuqua SA, Jordan VC, Katzenellenbogen JA, Korach KS, Maggi A, Muramatsu M, Parker MG, Gustafsson JA (2006). «International Union of Pharmacology. LXIV. Estrogen receptors». Pharmacol. Rev. 58 (4): 773-81. PMID 17132854. doi:10.1124/pr.58.4.8.

Levin ER (2005). «Integration of the extranuclear and nuclear actions of estrogen». Mol. Endocrinol. 19 (8): 1951-9. PMC 1249516. PMID 15705661. doi:10.1210/me.2004-0390.

Li X, Huang J, Yi P, Bambara RA, Hilf R, Muyan M (2004). «Single-chain estrogen receptors (ERs) reveal that the ERalpha/beta heterodimer emulates functions of the ERalpha dimer in genomic estrogen signaling pathways». Mol. Cell. Biol. 24 (17): 7681-94. PMC 506997. PMID 15314175. doi:10.1128/MCB.24.17.7681-7694.2004.

Hawkins MB, Thornton JW, Crews D, Skipper JK, Dotte A, Thomas P (septiembre de 2000). «Identification of a third distinct estrogen receptor and reclassification of estrogen receptors in teleosts». Proc Natl Acad Sci USA 97 (20): 10751-6. PMC 27095. PMID 11005855. doi:10.1073/pnas.97.20.10751.

Couse JF, Lindzey J, Grandien K, Gustafsson JA, Korach KS (noviembre de 1997). «Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse». Endocrinology 138 (11): 4613-21. PMID 9348186. doi:10.1210/en.138.11.4613.

Babiker FA, De Windt LJ, van Eickels M, Grohe C, Meyer R, Doevendans PA (2002). «Estrogenic hormone action in the heart: regulatory network and function». Cardiovasc. Res. 53 (3): 709-19. PMID 11861041. doi:10.1016/S0008-6363(01)00526-0.

Ascenzi P, Bocedi A, Marino M (agosto de 2006). «Structure-function relationship of estrogen receptor alpha and beta: impact on human health». Mol Aspects Med 27 (4): 299-402. PMID 16914190. doi:10.1016/j.mam.2006.07.001.

Bourguet W, Germain P, Gronemeyer H (octubre de 2000). «Nuclear receptor ligand-binding domains: three-dimensional structures, molecular interactions and pharmacological implications». Trends Pharmacol Sci 21 (10): 381-8. PMID 11050318. doi:10.1016/S0165-6147(00)01548-0.

Kansra S, Yamagata S, Sneade L, Foster L, Ben-Jonathan N (2005). «Differential effects of estrogen receptor antagonists on pituitary lactotroph proliferation and prolactin release». Mol. Cell. Endocrinol. 239 (1-2): 27-36. PMID 15950373. doi:10.1016/j.mce.2005.04.008.

Bakas P, Liapis A, Vlahopoulos S, Giner M, Logotheti S, Creatsas G, Meligova AK, Alexis MN, Zoumpourlis V (diciembre de 2007). «Estrogen receptor alpha and beta in uterine fibroids: a basis for altered estrogen responsiveness». Fertil. Steril. 90 (5): 1878. PMID 18166184. doi:10.1016/j.fertnstert.2007.09.019.

Deroo BJ, Korach KS (2006). «Estrogen receptors and human disease». J. Clin. Invest. 116 (3): 561-70. PMC 2373424. PMID 16511588. doi:10.1172/JCI27987.

Zivadinovic D, Gametchu B, Watson CS (2005). «Membrane estrogen receptor-alpha levels in MCF-7 breast cancer cells predict cAMP and proliferation responses». Breast Cancer Res. 7 (1): R101-12. PMC 1064104. PMID 15642158. doi:10.1186/bcr958.

Björnström L, Sjöberg M (2004). «Estrogen receptor-dependent activation of AP-1 via non-genomic signalling». Nucl Recept 2 (1): 3. PMC 434532. PMID 15196329. doi:10.1186/1478-1336-2-3.

Lu Q, Pallas DC, Surks HK, Baur WE, Mendelsohn ME, Karas RH (2004). «Striatin assembles a membrane signaling complex necessary for rapid, nongenomic activation of endothelial NO synthase by estrogen receptor alpha». Proc. Natl. Acad. Sci. U.S.A. 101 (49): 17126-31. PMC 534607. PMID 15569929. doi:10.1073/pnas.0407492101.

Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, Masushige S, Gotoh Y, Nishida E, Kawashima H, Metzger D, Chambon P (1995). «Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase». Science 270 (5241): 1491-4. PMID 7491495. doi:10.1126/science.270.5241.1491.

Prossnitz ER, Arterburn JB, Sklar LA (2007). «GPR30: A G protein-coupled receptor for estrogen». Mol. Cell. Endocrinol. 265-266: 138-42. PMC 1847610. PMID 17222505. doi:10.1016/j.mce.2006.12.010.

Otto C, Rohde-Schulz B, Schwarz G, Fuchs I, Klewer M, Brittain D, Langer G, Bader B, Prelle K, Nubbemeyer R, Fritzemeier KH (2008). «G protein-coupled receptor 30 localizes to the endoplasmic reticulum and is not activated by estradiol.». Endocrinology. 149 (10): 4846-56. PMID 18566127. doi:10.1210/en.2008-0269.

Fabian CJ, Kimler BF (2005). «Selective estrogen-receptor modulators for primary prevention of breast cancer». J. Clin. Oncol. 23 (8): 1644-55. PMID 15755972. doi:10.1200/JCO.2005.11.005.

Harris HA, Albert LM, Leathurby Y, Malamas MS, Mewshaw RE, Miller CP, Kharode YP, Marzolf J, Komm BS, Winneker RC, Frail DE, Henderson RA, Zhu Y, Keith JC (2003). «Evaluation of an estrogen receptor-beta agonist in animal models of human disease». Endocrinology 144 (10): 4241-9. PMID 14500559. doi:10.1210/en.2003-0550.

Hewitt KN, Boon WC, Murata Y, Jones ME, Simpson ER (2003). «The aromatase knockout mouse presents with a sexually dimorphic disruption to cholesterol homeostasis». Endocrinology 144 (9): 3895-903. PMID 12933663. doi:10.1210/en.2003-0244.

Danilovich N, Babu PS, Xing W, Gerdes M, Krishnamurthy H, Sairam MR (2000). «Estrogen deficiency, obesity, and skeletal abnormalities in follicle-stimulating hormone receptor knockout (FORKO) female mice». Endocrinology 141 (11): 4295-308. PMID 11089565. doi:10.1210/en.141.11.4295.

Ohlsson C, Hellberg N, Parini P, Vidal O, Bohlooly-Y M, Bohlooly M, Rudling M, Lindberg MK, Warner M, Angelin B, Gustafsson JA (2000). «Obesity and disturbed lipoprotein profile in estrogen receptor-alpha-deficient male mice». Biochem. Biophys. Res. Commun. 278 (3): 640-5. PMID 11095962. doi:10.1006/bbrc.2000.3827.

Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA (1996). «Cloning of a novel receptor expressed in rat prostate and ovary». Proc. Natl. Acad. Sci. U.S.A. 93 (12): 5925-30. PMC 39164. PMID 8650195. doi:10.1073/pnas.93.12.5925.

nih.gov

ncbi.nlm.nih.gov

Levin ER (2005). «Integration of the extranuclear and nuclear actions of estrogen». Mol. Endocrinol. 19 (8): 1951-9. PMC 1249516. PMID 15705661. doi:10.1210/me.2004-0390.

Yaghmaie F, Saeed O, Garan SA, Freitag W, Timiras PS, Sternberg H (2005). «Caloric restriction reduces cell loss and maintains estrogen receptor-alpha immunoreactivity in the pre-optic hypothalamus of female B6D2F1 mice». Neuro Endocrinol. Lett. 26 (3): 197-203. PMID 15990721.

Htun H, Holth LT, Walker D, Davie JR, Hager GL (1 de febrero de 1999). «Direct visualization of the human estrogen receptor alpha reveals a role for ligand in the nuclear distribution of the receptor». Mol Biol Cell 10 (2): 471-86. PMC 25181. PMID 9950689.

Deroo BJ, Korach KS (2006). «Estrogen receptors and human disease». J. Clin. Invest. 116 (3): 561-70. PMC 2373424. PMID 16511588. doi:10.1172/JCI27987.

Björnström L, Sjöberg M (2004). «Estrogen receptor-dependent activation of AP-1 via non-genomic signalling». Nucl Recept 2 (1): 3. PMC 434532. PMID 15196329. doi:10.1186/1478-1336-2-3.

Prossnitz ER, Arterburn JB, Sklar LA (2007). «GPR30: A G protein-coupled receptor for estrogen». Mol. Cell. Endocrinol. 265-266: 138-42. PMC 1847610. PMID 17222505. doi:10.1016/j.mce.2006.12.010.

Fabian CJ, Kimler BF (2005). «Selective estrogen-receptor modulators for primary prevention of breast cancer». J. Clin. Oncol. 23 (8): 1644-55. PMID 15755972. doi:10.1200/JCO.2005.11.005.

Jensen EV, Jordan VC (1 de junio de 2003). «The estrogen receptor: a model for molecular medicine» (abstract). Clin. Cancer Res. 9 (6): 1980-9. PMID 12796359.

Receptor de estrógeno (Spanish Wikipedia)

aacrjournals.org

clincancerres.aacrjournals.org

archive.org

doi.org

dx.doi.org

elsevier.com

linkinghub.elsevier.com

molbiolcell.org

nel.edu

nih.gov

ncbi.nlm.nih.gov

uc.edu